中国P站

ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Effect of Silver Sulfadiazine on Mature Mixed Bacterial Biofilms on Voice Prostheses

*Corresponding Author:

Received Date: Feb 28, 2025 / Published Date: Mar 30, 2025

Citation: Tsung-Lin Y (2025) Effect of Silver Sulfadiazine on Mature Mixed Bacterial Biofilms on Voice Prostheses. Otolaryngol (Sunnyvale) 15: 627.DOI: 10.4172/2161-119X.1000627

Copyright: © 2025 Tsung-Lin Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Voice prostheses (VPs) are commonly used in patients who have undergone laryngectomy, serving as essential tools for speech rehabilitation. However, these prostheses are prone to colonization by pathogenic microorganisms, forming mature mixed bacterial biofilms that can lead to infection, reduced prosthetic function, and overall clinical complications. This study aims to evaluate the effect of silver sulfadiazine (SSD) on mature mixed bacterial biofilms on voice prostheses. Using an in vitro model, we analyzed the impact of SSD on biofilm viability, structure, and composition over a 7-day period. Bacterial strains commonly associated with voice prosthesis infections, including Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis, were cultured to form mixed biofilms on silicone voice prostheses. Silver sulfadiazine was applied at concentrations of 0.5%, 1%, and 2%. Biofilm disruption was assessed using confocal laser scanning microscopy (CLSM) and the XTT assay for metabolic activity. The results indicated that SSD significantly reduced biofilm viability, with the 1% SSD concentration showing the most substantial effect in disrupting biofilm formation. Moreover, SSD was found to affect both the structural integrity and the metabolic activity of the biofilm. This study provides valuable insights into the potential role of silver sulfadiazine as a therapeutic agent for managing bacterial colonization on voice prostheses, offering a promising alternative for improving prosthesis longevity and patient outcomes.

International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.